Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Finke

Showing results (161-170 of 180) with videos related to

Pageof 18
Sort By:
Brain, Behavior, and Immunity|June 10, 2025
Anti-VGLUT2 autoantibodies in neurological diseasesMerle Corty, Friederike A Arlt, Kathrin Borowski, et al.
The Lancet. Psychiatry|December 12, 2025
The distinctive psychopathology of NMDAR-antibody encephalitis compared with primary psychoses: an international, multicentre, retrospective phenotypic analysisAdam Al-Diwani, Jakob Theorell, Tarek Zghoul, et al.
Eclinicalmedicine|February 9, 2024
Predictors of non-recovery from fatigue and cognitive deficits after COVID-19: a prospective, longitudinal, population-based studyTim J Hartung, Thomas Bahmer, Irina Chaplinskaya-Sobol, et al.
Journal of Neurology|March 25, 2025
Intravenous immunoglobulin as first-line acute treatment in adults with autoimmune encephalitis caused by antibodies to NMDAR, LGI1 and CASPR2Joyce Christin Rittel, Dominica Hudasch, Kathrin Doppler, et al.
Frontiers in Immunology|July 25, 2024
HLA and KIR genetic association and NK cells in anti-NMDAR encephalitisVicente Peris Sempere, Guo Luo, Sergio Muñiz-Castrillo, et al.
Frontiers in Medicine|July 3, 2023
Fighting Post-COVID and ME/CFS - development of curative therapiesCarmen Scheibenbogen, Judith Theresia Bellmann-Strobl, Cornelia Heindrich, et al.
Scientific Reports|June 17, 2026
Correction: How pain intensity and mental disorders shape chronic pain sick leave and quality of life in the general Spanish populationChristian Neumann, Tim J Hartung, Klara Boje, et al.
Scientific Reports|February 25, 2025
Factors associated with reduction in quality of life after SARS-CoV-2 infectionChristian Neumann, Tim J Hartung, Klara Boje, et al.
Annals of Clinical and Translational Neurology|December 11, 2014
High prevalence of NMDA receptor IgA/IgM antibodies in different dementia typesSarah Doss, Klaus-Peter Wandinger, Bradley T Hyman, et al.
Infection|April 8, 2024
Definition of the Post-COVID syndrome using a symptom-based Post-COVID score in a prospective, multi-center, cross-sectoral cohort of the German National Pandemic Cohort Network (NAPKON)Katharina S Appel, Carolin Nürnberger, Thomas Bahmer, et al.
Pageof 18

Showing results (161-170 of 180) with videos related to

Sort By:
Pageof 18
Brain, Behavior, and Immunity|June 10, 2025
Anti-VGLUT2 autoantibodies in neurological diseasesMerle Corty, Friederike A Arlt, Kathrin Borowski, et al.
The Lancet. Psychiatry|December 12, 2025
The distinctive psychopathology of NMDAR-antibody encephalitis compared with primary psychoses: an international, multicentre, retrospective phenotypic analysisAdam Al-Diwani, Jakob Theorell, Tarek Zghoul, et al.
Eclinicalmedicine|February 9, 2024
Predictors of non-recovery from fatigue and cognitive deficits after COVID-19: a prospective, longitudinal, population-based studyTim J Hartung, Thomas Bahmer, Irina Chaplinskaya-Sobol, et al.
Journal of Neurology|March 25, 2025
Intravenous immunoglobulin as first-line acute treatment in adults with autoimmune encephalitis caused by antibodies to NMDAR, LGI1 and CASPR2Joyce Christin Rittel, Dominica Hudasch, Kathrin Doppler, et al.
Frontiers in Immunology|July 25, 2024
HLA and KIR genetic association and NK cells in anti-NMDAR encephalitisVicente Peris Sempere, Guo Luo, Sergio Muñiz-Castrillo, et al.
Frontiers in Medicine|July 3, 2023
Fighting Post-COVID and ME/CFS - development of curative therapiesCarmen Scheibenbogen, Judith Theresia Bellmann-Strobl, Cornelia Heindrich, et al.
Scientific Reports|June 17, 2026
Correction: How pain intensity and mental disorders shape chronic pain sick leave and quality of life in the general Spanish populationChristian Neumann, Tim J Hartung, Klara Boje, et al.
Scientific Reports|February 25, 2025
Factors associated with reduction in quality of life after SARS-CoV-2 infectionChristian Neumann, Tim J Hartung, Klara Boje, et al.
Annals of Clinical and Translational Neurology|December 11, 2014
High prevalence of NMDA receptor IgA/IgM antibodies in different dementia typesSarah Doss, Klaus-Peter Wandinger, Bradley T Hyman, et al.
Infection|April 8, 2024
Definition of the Post-COVID syndrome using a symptom-based Post-COVID score in a prospective, multi-center, cross-sectoral cohort of the German National Pandemic Cohort Network (NAPKON)Katharina S Appel, Carolin Nürnberger, Thomas Bahmer, et al.
Pageof 18